Acetylpyrazine → 4-((4-(1H-pyrazol-5-yl)pyrimidin-2-ylamino)methyl)-N-(2-aminophenyl)benzamide
반응식
[NH2:1][C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][C:3]=1[NH:8][C:9](=[O:30])[C:10]1[CH:15]=[CH:14][C:13]([CH2:16][NH:17][C:18]2[N:23]=[C:22]([C:24]3C=NC=C[N:25]=3)[CH:21]=[CH:20][N:19]=2)=[CH:12][CH:11]=1.[N:31]1C=CN=[CH:33][C:32]=1C(=O)C.N1NC(C(=O)C)=CC=1>>[NH2:1][C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][C:3]=1[NH:8][C:9](=[O:30])[C:10]1[CH:15]=[CH:14][C:13]([CH2:16][NH:17][C:18]2[N:23]=[C:22]([C:24]3[NH:25][N:31]=[CH:32][CH:33]=3)[CH:21]=[CH:20][N:19]=2)=[CH:12][CH:11]=1참가 물질
4
실험 절차
Title compound was obtained according to the scheme 6 similarly to the compound 26a (Example 29) using instead of 1-pyrazin-2-yl-ethanone as the starting material 1-(2H-pyrazol-3-yl)-ethanone (Table 11). Characterization of the title compound is provided in the Table 12.
출처 및 근거
- ORD 기록
- ord-888c5a70c3774630adf61b0bed8133f9
- 출처 데이터셋
- uspto-grants-2007_08
- 특허 번호
- US07253204B2
반응 노트
불러오는 중…